Skip Nav Destination
Fixed-Dose-Rate Gemcitabine in Combination with Oxaliplatin in Patients with Metastatic Pancreatic Cancer Refractory to Standard-Dose-Rate Gemcitabine: A Single-Institute Study
Oncology (2009) 76 (5): 333–337.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Anabela Barros
- Catarina Pulido
- Manuela Machado
- Maria Brito
- Nuno Couto
- Olga Sousa
- Sónia Melo
- Hélder Mansinho
International Journal of Oncology (2021) 59 (6)
- A. J. Muñoz Martín
- J. Adeva
- J. Martínez-Galán
- J. J. Reina
- M. Hidalgo
Clinical and Translational Oncology (2017) 19 (12): 1423.
- Giuseppe Aprile
- Francesca V. Negri
- Francesco Giuliani
- Elisa De Carlo
- Davide Melisi
- Francesca Simionato
- Nicola Silvestris
- Oronzo Brunetti
- Francesco Leone
- Donatella Marino
- Daniele Santini
- Emanuela Dell’Aquila
- Tea Zeppola
- Marco Puzzoni
- Mario Scartozzi
Critical Reviews in Oncology/Hematology (2017) 115: 1.
- Gero Wieners
- Alexander Christian Schippers
- Federico Collettini
- Dirk Schnapauff
- Bernd Hamm
- Peter Wust
- Hanno Riess
- Bernhard Gebauer
Hepatobiliary & Pancreatic Diseases International (2015) 14 (5): 530.
- O.E. Rahma
- A. Duffy
- D.J. Liewehr
- S.M. Steinberg
- T.F. Greten
Annals of Oncology (2013) 24 (8): 1972.
- Jeong Youp Park
The Korean Journal of Gastroenterology (2011) 57 (4): 207.
- Kyu-Hyoung Lim
- Tae-Yong Kim
- Kyung-Hun Lee
- Sae-Won Han
- Do-Youn Oh
- Seock-Ah Im
- Tae-You Kim
- Yung-Jue Bang
Cancer Chemotherapy and Pharmacology (2011) 68 (4): 1017.
- F. Meriggi
- A. Zaniboni
Journal of Chemotherapy (2010) 22 (5): 298.
- Christopher Cao
- Tristan D Yan
- David L Morris
- Lourens Bester
Tumori Journal (2010) 96 (6): 955.
